• Return to Headlines

Heron Therapeuti Shares Down 45.9% Since SmarTrend's Sell Call (HRTX)

By James Quinn

SmarTrend identified a Downtrend for Heron Therapeuti (NASDAQ:HRTX) on February 18th, 2020 at $20.76. In approximately 1 month, Heron Therapeuti has returned 45.91% as of today's recent price of $11.23.

Heron Therapeuti share prices have moved between a 52-week high of $26.81 and a 52-week low of $9.60 and are now trading 17% above that low price at $11.23 per share. Over the last five market days, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has declined 3.2%.

Heron Therapeutics, Inc. operates as a biotechnology company. The Company offers proprietary biochronomer drug delivery technology which is designed to improve the therapeutic profile of injectable pharmaceuticals, as well as focuses on identifying current therapies with the potential to be reformulated.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Heron Therapeuti.

Log in and add Heron Therapeuti (HRTX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights heron therapeuti

Ticker(s): HRTX